- Drugs
- Vaccines
- Antibiotics
- Antifungals
- Parasiticides
- Anti-Viral Drugs
- Others
- Feed Products
- Nutritional Feed
- Medicated Feed
- Non-Medicated Feed
Swine Healthcare Market size was valued at USD 3.12 billion in 2023, growing at a CAGR of 5.4% from 2024 to 2030. The global market provides a detailed overview and can be segmented by product type, disease type, route of administration, distribution channel, and region. By product type, the swine healthcare market has been segmented into drugs and feed products. By product type, the feed products segment is expected to have the fastest growth rate over the forecasted period due to the high demand for feed products among a large proportion of people as swine diseases continuously increase. By disease type, the swine healthcare market has been segmented into viral infections, bacterial infections, parasitic infections, and fungal infections. By disease type, the viral infection segment is anticipated to increase day by day due to a high spreading rate of viral diseases among individuals, which leads to an increase in the mortality rate. Thus, the swine healthcare market is expanding by the spreading of viral diseases globally. By route of administration, the swine healthcare market has been segmented into oral, and parenteral. By route of administration, the parenteral segment held the largest revenue share of the swine healthcare market in the current period and is expected to have a steady growth rate in the coming next few years due to its high efficiency and medication in lesser time. Based on the distribution channel, the segment has been segregated into veterinary hospitals, veterinary pharmacies, and online pharmacies.
Swine Healthcare Market Key Development:
- In April 2022, Amlan International launched two new natural alternatives to antibiotics for poultry and livestock.
- In Sept 2022, Merck Animal Health completed minority investment in leeO precision farming.
Swine Healthcare Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
5.4%
Largest Market
North-America
Fastest Growing Market
Asia pacific
Swine Healthcare Market Dynamics
The increasing incidents of swine diseases in pigs are anticipated to increase in the adoption of swine healthcare products. Also, the increasing dependency on poultry and swine products have expected to be one of the swine healthcare market drivers. Apart from this, with the presence of key players and the government to maintain animal health is further expected to boost the market growth. Moreover, the growing awareness of pork-transmitted diseases is expected to rise the adoption of swine healthcare products.
North-America got significant share
Swine Healthcare Market Regional Analysis
By region, North America accounts for a major market share in the global swine healthcare market owing to the growing animal healthcare and increasing government initiatives in animal welfare combined with the growth in the pork-eating population. Furthermore, the swine healthcare market is anticipated to be driven by the rising awareness of swine disease and favorable healthcare facilities for farm animals.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Swine Healthcare Market Segmentation
By Product Type
By Disease Type
- Viral Infections
- Bacterial Infections
- Parasitic Infection
- Fungal Infections
By Distribution Channel
- Veterinary Hospitals
- Veterinary Pharmacies
- Online Pharmacies
Frequently Asked Questions
The swine healthcare market size was valued at USD 3.12 billion in 2023
The swine healthcare market key players are: Zoetis (Pfizer, Inc.) (U.S.) Merck & Co. Inc. (U.S) Virbac S.A. (France) Boehringer Ingelheim Vetmedica (Germany) Elanco (U.S.) Bayer Animal Health (Germany) Ceva Sante Animale (France) Wilbur-Ellis Feed, LLC (U.S.) Vetoquinol S.A. (France)
The swine healthcare market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
| 1. Executive Summary |
| 2. Global Swine Healthcare Market Introduction |
| 2.1. Global Swine Healthcare Market - Taxonomy |
| 2.2. Global Swine Healthcare Market - Definitions |
| 2.2.1. Product Type |
| 2.2.2. Disease Type |
| 2.2.3. Distribution Channel |
| 2.2.4. Region |
| 3. Global Swine Healthcare Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Key Developments |
| 4. Global Swine Healthcare Market By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 4.1. Drugs |
| 4.1.1. Vaccines |
| 4.1.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.1.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 4.1.1.3. Market Opportunity Analysis |
| 4.1.2. Antibiotics |
| 4.1.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.1.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 4.1.2.3. Market Opportunity Analysis |
| 4.1.3. Antifungals |
| 4.1.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.1.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 4.1.3.3. Market Opportunity Analysis |
| 4.1.4. Parasiticides |
| 4.1.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.1.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 4.1.4.3. Market Opportunity Analysis |
| 4.1.5. Anti-Viral Drugs |
| 4.1.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.1.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 4.1.5.3. Market Opportunity Analysis |
| 4.2. Feed Products |
| 4.2.1. Nutritional Feed |
| 4.2.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 4.2.1.3. Market Opportunity Analysis |
| 4.2.2. Medicated Feed |
| 4.2.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 4.2.2.3. Market Opportunity Analysis |
| 4.2.3. Non-Medicated Feed |
| 4.2.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 4.2.3.3. Market Opportunity Analysis |
| 5. Global Swine Healthcare Market By Disease Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Viral Infections |
| 5 1 1 Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Bacterial Infections |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Parasitic Infection |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Fungal Infections |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6. Global Swine Healthcare Market By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Veterinary Hospitals |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Veterinary Pharmacies |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Online Pharmacies |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. Global Swine Healthcare Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Latin America |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. MEA |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. Global Swine Healthcare Market - Opportunity Analysis Index, By Disease Type, Product Type, Distribution Channel, , , , , and Region, 2024 - 2030 |
| 8. North America Swine Healthcare Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Product Type Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1. Drugs |
| 8.1.1.1. Vaccines |
| 8.1.1.2. Antibiotics |
| 8.1.1.3. Antifungals |
| 8.1.1.4. Parasiticides |
| 8.1.1.5. Anti-Viral Drugs |
| 8.1.2. Feed Products |
| 8.1.2.1. Nutritional Feed |
| 8.1.2.2. Medicated Feed |
| 8.1.2.3. Non-Medicated Feed |
| 8.2. Disease Type Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1. Viral Infections |
| 8.2.2. Bacterial Infections |
| 8.2.3. Parasitic Infection |
| 8.2.4. Fungal Infections |
| 8.3. Distribution Channel Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1. Veterinary Hospitals |
| 8.3.2. Veterinary Pharmacies |
| 8.3.3. Online Pharmacies |
| 8.4. Country Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.4.1. USA |
| 8.4.2. Canada |
| 9. Europe Swine Healthcare Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Product Type Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1. Drugs |
| 9.1.1.1. Vaccines |
| 9.1.1.2. Antibiotics |
| 9.1.1.3. Antifungals |
| 9.1.1.4. Parasiticides |
| 9.1.1.5. Anti-Viral Drugs |
| 9.1.2. Feed Products |
| 9.1.2.1. Nutritional Feed |
| 9.1.2.2. Medicated Feed |
| 9.1.2.3. Non-Medicated Feed |
| 9.2. Disease Type Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1. Viral Infections |
| 9.2.2. Bacterial Infections |
| 9.2.3. Parasitic Infection |
| 9.2.4. Fungal Infections |
| 9.3. Distribution Channel Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1. Veterinary Hospitals |
| 9.3.2. Veterinary Pharmacies |
| 9.3.3. Online Pharmacies |
| 9.4. Country Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1. Germany |
| 9.4.2. France |
| 9.4.3. Italy |
| 9.4.4. Spain |
| 9.4.5. UK |
| 9.4.6. Rest of Europe |
| 10. Asia Pacific Swine Healthcare Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Product Type Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Drugs |
| 10.1.1.1. Vaccines |
| 10.1.1.2. Antibiotics |
| 10.1.1.3. Antifungals |
| 10.1.1.4. Parasiticides |
| 10.1.1.5. Anti-Viral Drugs |
| 10.1.2. Feed Products |
| 10.1.2.1. Nutritional Feed |
| 10.1.2.2. Medicated Feed |
| 10.1.2.3. Non-Medicated Feed |
| 10.2. Disease Type Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1. Viral Infections |
| 10.2.2. Bacterial Infections |
| 10.2.3. Parasitic Infection |
| 10.2.4. Fungal Infections |
| 10.3. Distribution Channel Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1. Veterinary Hospitals |
| 10.3.2. Veterinary Pharmacies |
| 10.3.3. Online Pharmacies |
| 10.4. Country Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1. China |
| 10.4.2. Japan |
| 10.4.3. South Korea |
| 10.4.4. India |
| 10.4.5. Rest of APAC |
| 11. Latin America Swine Healthcare Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Product Type Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Drugs |
| 11.1.1.1. Vaccines |
| 11.1.1.2. Antibiotics |
| 11.1.1.3. Antifungals |
| 11.1.1.4. Parasiticides |
| 11.1.1.5. Anti-Viral Drugs |
| 11.1.2. Feed Products |
| 11.1.2.1. Nutritional Feed |
| 11.1.2.2. Medicated Feed |
| 11.1.2.3. Non-Medicated Feed |
| 11.2. Disease Type Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1. Viral Infections |
| 11.2.2. Bacterial Infections |
| 11.2.3. Parasitic Infection |
| 11.2.4. Fungal Infections |
| 11.3. Distribution Channel Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1. Veterinary Hospitals |
| 11.3.2. Veterinary Pharmacies |
| 11.3.3. Online Pharmacies |
| 11.4. Country Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1. Brazil |
| 11.4.2. Mexico |
| 11.4.3. Argentina |
| 11.4.4. Rest of Latin America |
| 12. MEA Swine Healthcare Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Product Type Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Drugs |
| 12.1.1.1. Vaccines |
| 12.1.1.2. Antibiotics |
| 12.1.1.3. Antifungals |
| 12.1.1.4. Parasiticides |
| 12.1.1.5. Anti-Viral Drugs |
| 12.1.2. Feed Products |
| 12.1.2.1. Nutritional Feed |
| 12.1.2.2. Medicated Feed |
| 12.1.2.3. Non-Medicated Feed |
| 12.2. Disease Type Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1. Viral Infections |
| 12.2.2. Bacterial Infections |
| 12.2.3. Parasitic Infection |
| 12.2.4. Fungal Infections |
| 12.3. Distribution Channel Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1. Veterinary Hospitals |
| 12.3.2. Veterinary Pharmacies |
| 12.3.3. Online Pharmacies |
| 12.4. Country Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1. GCC Countries |
| 12.4.2. South Africa |
| 12.4.3. Rest of MEA |
| 13. Competition Landscape |
| 13.1. Strategic Dashboard of Top Market Players |
| 13.2. Company Profiles (Introduction, Financial Analysis, By Product Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 13.2.1. Zoetis (Pfizer, Inc.) (U.S.) |
| 13.2.2. Merck & Co. Inc. (U.S) |
| 13.2.3. Virbac S.A. (France) |
| 13.2.4. Boehringer Ingelheim Vetmedica (Germany) |
| 13.2.5. Elanco (U.S.) |
| 13.2.6. Bayer Animal Health (Germany) |
| 13.2.7. Ceva Sante Animale (France) |
| 13.2.8. Wilbur-Ellis Feed, LLC (U.S.) |
| 13.2.9. Vetoquinol S.A. (France) |
| 14. Research Methodology |
| 15. Key Assumptions and Acronyms |
- Zoetis (Pfizer, Inc.) (U.S.)
- Merck & Co. Inc. (U.S)
- Virbac S.A. (France)
- Boehringer Ingelheim Vetmedica (Germany)
- Elanco (U.S.)
- Bayer Animal Health (Germany)
- Ceva Sante Animale (France)
- Wilbur-Ellis Feed, LLC (U.S.)
- Vetoquinol S.A. (France)